McFarlane Neil F.

Track

Insider profile

McFarlane Neil F.'s trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
10.82
Quantity 19,500
Value US$210,990
Transaction date
Proposed sale
Price
7.72
Quantity 91,817
Value US$708,827
Transaction date
Proposed sale
Price
35.21
Quantity 44,365
Value US$1,562,312
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
PlS Planned sale
18,288 -26.7%
81.09
US$752,960 		18,288 -26.7% 81.09 US$752,960
2026-02-02 2026-02-02
PrS Proposed sale
54,728
257.23
US$845,692 		54,728 257.23 US$845,692
2026-02-02 2026-02-02
PlS Planned sale
198 -39.8%
477.40
US$1,521,854 		198 -39.8% 477.40 US$1,521,854
2025-10-10 2025-10-10
PrS Proposed sale
19,500
10.82
US$210,990 		19,500 10.82 US$210,990
2025-10-10 2025-10-10
PlS Planned sale
19,500 -8.1%
10.82
US$210,908 		19,500 -8.1% 10.82 US$210,908
2025-02-14 2025-02-14
PlS Planned sale
30,544 -13.8%
8.05
US$245,962 		30,544 -13.8% 8.05 US$245,962
2025-02-14 2025-02-13
PlS Planned sale
61,273 -21.6%
7.86
US$481,428 		61,273 -21.6% 7.86 US$481,428
2025-02-13 2025-02-13
PrS Proposed sale
91,817
7.72
US$708,827 		91,817 7.72 US$708,827
2024-08-12 2024-08-12
PrS Proposed sale
44,365
35.21
US$1,562,312 		44,365 35.21 US$1,562,312
2024-08-09 2024-08-09
PrS Proposed sale
5,000
35.20
US$176,007 		5,000 35.20 US$176,007
2019-05-16 2019-05-16
PlS Planned sale
984 -3.5%
18.71
US$18,411 		984 -3.5% 18.71 US$18,411
2019-05-16 2019-05-15
PlS Planned sale
984 -3.4%
17.78
US$17,496 		984 -3.4% 17.78 US$17,496